Abstract
With the wide application of antibiotics, Acinetobacter baumannii infection has increased gradually. The clinical isolating rates of multidrug resistant (MDR) , extensive-drug resistant (XDR) and even pan-drug resistant (PDR) A. baumannii increase significantly. A. baumannii has become an important opportunistic pathogen in the nosocomial setting. The article reviews the resistance mechanism and therapeutic options of the extensive-drug resistant A. Baumannii. Key words: Acinetobacter baumannii; Extensive-drug resistance; Resistance mechanism; Therapeutic options
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
